The usage of anticholinergic medications in a low- and middle-income country: a longitudinal comparison of 2013–15 and 2020

The usage of anticholinergic medications in a low- and middle-income country: a longitudinal comparison of 2013–15 and 2020–22 datasets

Published:2024-09-12 Issue: Volume: Page:
ISSN:2210-7703
Container-title:International Journal of Clinical Pharmacy
language:en
Short-container-title:Int J Clin Pharm

Author:

Xu Xiang Jiang,Myint Phyo Kyaw,Lee Shaun Wen Huey,Ramasamy Kalavathy,Lim Siong Meng,Majeed Abu Bakar Abdul,Wong Yuet Yen,Mat Sumaiyah,Saedon Nor Izzati,Mahadzir Hazlina,Hasmukharay Kejal,Tan Maw Pin^ORCID

Funder

the Ministry of Higher Education Malaysia

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11096-024-01791-1.pdf

Reference42 articles.

1. Mur J, Cox SR, Marioni RE, et al. Increase in anticholinergic burden from 1990 to 2015: age-period-cohort analysis in UK biobank. Br J Clin Pharmacol. 2022;88:983–93.

2. Collamati A, Martone AM, Poscia A, et al. Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence. Aging Clin Exp Res. 2016;28:25–35.

3. Matsumoto A, Yoshimura Y, Nagano F, et al. Exploring the impact of anticholinergic burden on urinary independence: insights from a post-stroke cohort of older adults. Int J Clin Pharm. 2024;46:910–7. https://doi.org/10.1007/s11096-024-01725-x.

4. de Germay S, Rueter M, Montastruc F, et al. Trends of atropinic (anticholinergic) exposure in the elderly: a 10-year analysis in the French EGB database. Fundam Clin Pharmacol. 2019;33:471–8.

5. Morin L, Johnell K, Laroche ML, et al. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;10:289.